TNF and neurodegenerative disease: Ultimately, combination therapies, using sTNF/TNFR1 antagonists together with TNFR2 agonists, may rebalance pathologically deregulated TNF signaling and induce tissue repair and might be a novel superior therapeutic concept to treat a multitude of inflammatory and degenerative diseases.